Extreme poverty first: An argument on the equitable distribution of the COVID-19 vaccine in Peru

Dev World Bioeth. 2024 Jun;24(2):97-101. doi: 10.1111/dewb.12391. Epub 2023 Feb 3.

Abstract

Effective vaccines for COVID-19 are already available to humankind. In Peru, 86 million doses were administered to cover the demand for 33 million Peruvian people. Hence, vaccination has been prioritized in groups: health personnel, subjects with pre-existing health conditions and those over 65 years of age. However, given the social problems and the public health situation in Peru, this work defends that the priority of vaccination should be focused on the population living in extreme poverty. The method used was an ethical argumentation on the distribution of scarce antiSARS-CoV2 vaccine in Peru. This argument is based on the analysis of the Peruvian population living in extreme poverty, which presents different layers of vulnerability, and that, in the face of an eventual SARS-CoV2 infection, these would be exacerbated one after the other, through a cascade effect. This scenario would give rise to new vulnerabilities to those already existing, causing greater damage. Vaccination efforts on this key population would give them the opportunity to continue to find ways to bring food to their homes, significantly reducing the risk of contagion in their environment and mitigating the devastating effect of the local diseases to which they are already exposed. Four objections related to this argument are raised with their corresponding responses. Priority access to the vaccine would significantly reduce the humanitarian harm to people living in extreme poverty, prevailing the principles of justice and equity.

Keywords: COVID‐19; Peru; ethics; poverty; vaccines.

MeSH terms

  • COVID-19 Vaccines* / administration & dosage
  • COVID-19 Vaccines* / supply & distribution
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Health Care Rationing / ethics
  • Health Equity
  • Health Services Accessibility
  • Humans
  • Pandemics
  • Peru / epidemiology
  • Poverty*
  • Public Health
  • SARS-CoV-2*
  • Vaccination / ethics
  • Vulnerable Populations

Substances

  • COVID-19 Vaccines